Highland Long/Short Healthcare Fund Class C (HHCCX)

15.55
Net Asset Value
+0.13%
1 Day
+9.82%
Year-to-Date
Overall Morningstar Rating
Long/short equity
Style or Category
No Load
Sales Expenses
3.25%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks to achieve its investment objective by investing at least 80% of the value of its total assets (net assets plus any borrowings for investment purposes) under normal circumstances in securities of companies principally engaged in the design, development, production, sale, management or distribution of products, services or facilities used for or in connection with healthcare or medicine ("healthcare companies"). It is non-diversified.

Performance

1 month+2.17% 3 years+12.83%
3 months+9.58% 5 years+10.86%
1 year+9.00% Since inception+9.79%
Data through --

Peer Comparisonvs. Long/short equity

 HHCCXCategory
Performance 5-yr return+10.86%+6.85%
Expense ratio3.25%1.90%
Risk 5 year sharpe ratio0.820.78
Net assets$489.0M$400.8M
Average market cap$5.6B$37.5B
Average P/E28.418.2
Portfolio turnover538%538%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyHighland Funds
Fund manager & tenureMichael Gregory / 4 Years
Minimal initial investment$2,500.00
Minimum IRA investment$50.00

Holdings

Cash49.57%
U.S. stock40.48%
International stock8.54%
Fixed income1.41%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 94.68%
Hardware 2.03%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Top 10 Holdings
Portfolio weighting
RMD ResMed Inc3.95%
VAR Varian Medical Systems Inc3.66%
JNJ Johnson & Johnson3.57%
NUVA NuVasive Inc3.56%
HUM Humana Inc3.27%
-- 3.26%
WOOF VCA Inc3.13%
LH Laboratory Corporation of America Holdings3.09%
ABT Abbott Laboratories2.88%
LDRH LDR Holding Corp2.85%

To view my watchlist

Not a member yet?

Sign up now for a free account